Skip to main content

Table 2 Cost-effectiveness analysis of base-case for patients with ESCC

From: A cost-effectiveness modeling study of treatment interventions for stage I to III esophageal squamous cell carcinoma

Treatment interventions

Total cost per patient (US $)

QALY

LYG

ICER (US$/QALY)

ICER (US$/LYG)

Stage I

 EMR

4485.6

3.045

4.363

Reference

Reference

 Esophagectomy

5582.6

3.033

4.353

Dominated

Dominated

 EMR followed by ablation

4753.9

2.884

4.136

Dominated

Dominated

Stage II and III

 CRT

4738.9

2.143

2.821

Reference

Reference

 CRT followed by surgery

6707

3.048

4.013

2172.8

1650.9

 Esophagectomy

7622.8

2.664

3.509

Dominated

Dominated